Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sichong tablet and Internet-plus management for chronic lower-extremity deep venous thrombosis
ChiCTR2100047815Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Sichong tablet in deep vein thrombosis (DVT) (4 arms), sponsored by Affiliated Hospital of Shandong University of Traditional Chinese Medicine. Primary endpoints: Symptom quantification score, Curative effect of traditional Chinese medicine syndrome and 11 more. Started Jan 2019; status: recruiting.
02
Drugs
Sichong tablet
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR2100047815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047815.